Proto-oncogene tyrosine-protein kinase receptor Ret Phospho-Tyr1096 (RET pY1096) Antibody

Product Graph
312€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Proto-oncogene tyrosine-protein kinase receptor Ret Phospho-Tyr1096 (RET pY1096) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx218258
tested applications
WB

Description

Ret (pY1096) Antibody is a Rabbit Polyclonal against Ret (pY1096).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Proto-oncogene tyrosine-protein kinase receptor Ret Phospho-Tyr1096 (RET pY1096)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Assay Data
Modification: Phosphorylation // Target Modification: Tyr1096
Recommended Dilution
WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by affinity chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatography using non-phosphopeptide.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
WB
Buffer
PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P07949
Gene ID
5979
OMIM
114500
Background
Antibody anti-RET
Status
RUO
Note
Concentration: 1 mg/ml -

Descripción

Related Products

EH1750

Human RET (Proto-oncogene tyrosine-protein kinase receptor Ret) ELISA Kit

Ver Producto
abx005602

Retinol (RET) Antibody

RET Antibody is a Rabbit Polyclonal Antibody against RET.

Ver Producto
abx012225

Retinol (RET) Antibody

This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Ver Producto